Skip to main content
. Author manuscript; available in PMC: 2024 Dec 12.
Published in final edited form as: Soc Sci Med. 2024 Mar 7;346:116734. doi: 10.1016/j.socscimed.2024.116734

Table 1B.

Gender-affirming therapy characteristics.

Characteristic Overall, N = 2981 Transmasculine, N = 1521 Transfeminine, N = 1461
Gender-Affirming Genital Surgery
Feminizing Surgery 26 (8.7%) 0 (0%) 26 (18%)
Masculinizing Surgery 22 (7.4%) 22 (14%) 0 (0%)
None 250 (84%) 130 (86%) 120 (82%)
Time on Gender-Affirming Hormone Therapy (Years) 2.9 (1.7, 5.1) 2.9 (1.8, 4.9) 3.1 (1.7, 5.7)
1

n (%); Median (IQR).